Clinical Trials Browser

Hematologic Diseases × Disulfides × 90 days × Clear all

NCT04572815 2026-01-02

Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant

Phase 2 Active not recruiting

Hematologic Diseases